Caffeine May Reduce Fatty Liver Disease

August 19, 2013

2 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal

SINGAPOREIncreased caffeine intake may reduce fatty liver in individuals with non-alcoholic fatty liver disease (NAFLD), according to researchers from Duke-NUS Graduate Medical School and Duke University School of Medicine.

Worldwide, 70% of people diagnosed with diabetes and obesity have NAFLD, the major cause of fatty liver not due to excessive alcohol consumption. This condition is rising in Singapore and in the U.S., 30% of people have this condition. The only current treatment for NAFLD is diet and exercise.

Using cell culture and mouse models, the study authorsled by Paul Yen, M.D., associate professor and research fellow, and Rohit Sinha, Ph.D of the Duke-NUS Graduate Medical Schools Cardiovascular and Metabolic Disorders Program in Singaporeobserved that caffeine stimulates the metabolization of lipids stored in liver cells and decreased the fatty liver of mice that were fed a high-fat diet. These findings suggest that consuming the equivalent caffeine intake of four cups of coffee or tea a day may be beneficial in preventing and protecting against the progression of NAFLD in humans.
This is the first detailed study of the mechanism for caffeine action on lipids in liver and the results are very interesting," Yen said. Coffee and tea are so commonly consumed and the notion that they may be therapeutic, especially since they have a reputation for being 'bad' for health, is especially enlightening."
The team said this research could lead to the development of caffeine-like drugs that do not have the usual side effects related to caffeine, but retain its therapeutic effects on the liver. It could serve as a starting point for studies on the full benefits of caffeine and related therapeutics in humans.

Previous research has shown that drinking two or more cups of coffee a day, while taking Tamoxafinthe widely-used cancer drugmay help decrease the risk of breast cancer recurring in patients.

The findings of the study will be published in the September issue of the journal Hepatology.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like